Foundation Sponsors National Lymphoma Awareness Week

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 10
Volume 6
Issue 10

LOS ANGELES-The Lymphoma Research Foundation of America launched its second annual National Lymphoma Awareness Week on October 12. Actress Kelly Lynch, whose sister Robyn Lynch is a lymphoma survivor, served as honorary chair of the week, which featured a slate of events to inform the public about this cancer.

LOS ANGELES—The Lymphoma Research Foundation of America launched its second annual National Lymphoma Awareness Week on October 12. Actress Kelly Lynch, whose sister Robyn Lynch is a lymphoma survivor, served as honorary chair of the week, which featured a slate of events to inform the public about this cancer.

Robin and Kelly Lynch spoke at the educational forum organized by the Foundation last year in Los Angeles regarding their personal experiences. Robyn was diagnosed with Hodgkin’s disease in July 1995. Kelly has stood by her sister’s side through her lymphoma treatment and recovery. This winter, the actress will be seen in the film Homegrown with Billy Bob Thorton and will star in Disney’s feature film Mr. Magoo.

On October 18, an all-day educational forum for lymphoma patients, their families, and health care providers was held in Vienna, Virginia. Awareness Week concluded with the presentation of the first Paul Tsongas Memorial Awards (see People & Places on page 53).

Recent Videos
According to Jorge Nieva, MD, there are a multitude of things that can be explored to enhance the treatment landscape for lung cancer.
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
Related Content